1Y Annualised Return
▼-48.94%
3Y Annualised Return
▼-32.69%
5Y Annualised Return
▼-23.18%
Vanta Bioscience SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹51,34,117 (-21.01%)
Daily SIP of ₹25,000 would have become ₹51,34,117 in 1 year with a gain of ₹-13,65,882 (-21.01%)
Vanta Bioscience Stock Performance
Today’s Low - High
27.32
27.32
27.32
27.32
52 Week Low - High
19.08
64.84
19.08
64.84
Open
27.32
Prev. Close
26.80
Volume
750.00
Total Traded Value
20490.00
Vanta Bioscience Fundamental
Market Cap (in crs)
17.24
Face Value
10
Turnover (in lacs)
0.20
Key Metrics
Qtr Change %
57.87% Fall from 52W High
-11.2
Dividend yield 1yr %
0
Vanta Bioscience Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
27.32
Current Price
5Day EMA
26.60
10Day EMA
25.60
12Day EMA
25.30
20Day EMA
24.60
26Day EMA
24.50
50Day EMA
26.10
100Day EMA
31.40
200Day EMA
40.90
5Day SMA
26.60
10Day SMA
25.50
20Day SMA
23.40
30Day SMA
22.80
50Day SMA
24.60
100Day SMA
32.10
150Day SMA
37.60
200Day SMA
43.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 750 Rs | 750 Rs |
Week Rs | 1125 Rs | 1125 Rs |
Month Rs | null Rs | null Rs |
Resistance & Support
27.32
Pivot
Resistance
First Resistance
27.32
Second Resistance
27.32
Third Resistance
27.32
Support
First Support
27.32
Second support
27.32
Third Support
27.32
Relative Strength Index
65.67
Money Flow Index
89.80
MACD
0.81
MACD Signal
0.12
Average True Range
0.80
Average Directional Index
24.82
Rate of Change (21)
31.60
Rate of Change (125)
-39.29
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 24.14 | 3.4 | 9.5 | 4.47 | 0.68% | 2.52% | -36.14% | -41.11% | -83.05% | 0.00% | 0.79 | 47.87 | 1.79 | |
- | 32.20 | 3.22 | 10.84 | 4.24 | 6.52% | 16.12% | -44.08% | -50.35% | 18.38% | 0.00% | 0.00 | 47.87 | -4.25 | |
- | 26.07 | 22.5 | 142.37 | 76.00 | 2.17% | 2.57% | 9.29% | 0.00% | 0.00% | 0.00% | 20.97 | 47.87 | 2.25 | |
- | 7.05 | 9.8 | 28.9 | 15.95 | 10.24% | 26.24% | 0.00% | -19.35% | -37.94% | 0.00% | 16.94 | 47.87 | 0.71 | |
- | 16.30 | 12.06 | 26.98 | 15.33 | 3.21% | -3.31% | -19.84% | -30.27% | -13.88% | 0.00% | 4.00 | 47.87 | 0.82 | |
- | 8.90 | 36.02 | 120.75 | 37.15 | 8.15% | -13.22% | -49.35% | 0.00% | 0.00% | 0.00% | 22.54 | 47.87 | 1.01 |
Vanta Bioscience Latest News
Vanta Bioscience Company background
Founded in: 2016
Managing director: Dopesh Raja Mulakala
Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name Vanta Bioscience Private Limited. The Company converted into a Public Limited Company and the name was changed to Vanta Bioscience Limited on 17th March 2017.The Company is presently engaged in the business of Preclinical Activities. The Company provides risk assessment services for evaluating safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of product. The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe. One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms.The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as Vanta Bioscience (a toxicology division and commenced commercial activities in April, 2017. VBS has state of the art facilities and infrastructure necessary for conduct of all kind of toxicology studies for Chemicals, Pharmaceuticals, Cosmetics, Agrochemicals like Pesticides, Insecticides, Excipients, Novel Feed Additives. In addition, the Company conducts preclinical proofofconcept (PoC) studies for novel pharmaceuticals and products intended for new indications in variety of animal models of human diseases through a robust process of validation. In September 2017, the Company came up with a Public Issue of 15,12,000 Equity Shares by raising money from public aggregating to Rs 7.56 Crore.In 201819, Vanta Clinical Research Limited and Vayam Research Solutions Limited became the subsidiaries of the Company.
As of 13 Jun, 2025, VANTABIO share price is ₹27.3. The stock opened at ₹27.3 and had closed at ₹26.8 the previous day. During today’s trading session, VANTABIO share price moved between ₹27.32 and ₹27.32, with an average price for the day of ₹27.00. Over the last 52 weeks, the stock has recorded a low of ₹19.08 and a high of ₹64.84. In terms of performance, VANTABIO share price has declined by 35.8% over the past six months and has declined by 48.94% over the last year.
Vanta Bioscience FAQs
How to buy Vanta Bioscience shares?
You can easily buy Vanta Bioscience shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Vanta Bioscience stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account